Descargar 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series) de Abdul W. Basit,Simon Gaisford Ebooks, PDF, ePub, 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series) Descarga gratuita
3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series) de Abdul W. Basit,Simon Gaisford
Descripción - Reseña del editor 3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics.Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award.Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry. Contraportada 3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Professor Abdul Basit is a Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul's research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. His research has been translated into the design of new technologies and improved disease treatments, many of which have been commercialised. Abdul is also a serial entrepreneur and has filed multiple patents, is the recepient of several research awards and has founded 3 companies (Kuecept, Intract Pharma, FabRx). He further serves as a consultant to many pharmaceutical organisations and is on the advisory boards of scientific journals, healthcare and charitable bodies.Professor Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters, 4 authored books and is the recipient of multiple research awards. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, translating his expertise by co-founding FabRx. Simon is also an expert in the physicochemical characterisation of compounds and formulations with thermal methods and calorimetry. Biografía del autor Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.
Detalles del Libro
- Name: 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series)
- Autor: Abdul W. Basit,Simon Gaisford
- Categoria: Libros,Libros universitarios y de estudios superiores,Medicina y ciencias de la salud
- Tamaño del archivo: 9 MB
- Tipos de archivo: PDF Document
- Descargada: 435 times
- Idioma: Español
- Archivos de estado: AVAILABLE
Descargar 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series) de Abdul W. Basit,Simon Gaisford Ebooks, PDF, ePub
Aaps advances in the pharmaceutical sciences series the aaps advances in the pharmaceutical sciences series published in partnership with the american association of pharmaceutical scientists is designed to deliver volumes authored by opinion leaders and authorities from around the globe addressing innovations in drug research and development and best practice for scientists and industry professionals in the pharma and biotech industries
3d printing of pharmaceuticals springerlink 3d printing is forecast to revolutionise the pharmaceutical sector changing the face of medicine development manufacture and use potential applications range from preclinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine
3d printing of pharmaceuticals abdul basit springer this book is first comprehensive overview of 3d printing technologies in the pharmaceutical industry and is the definitive resource for anyone thinking of developing or using 3d printing technology for pharmaceutical industrial applicationsom single crystals through to complex structures
3d printing of pharmaceuticals aaps advances in the 3d printing of pharmaceuticals aaps advances in the pharmaceutical sciences series 31 band 31 basit abdul w gaisford simon fremdsprachige bücher
3d printing techniques in the pharmaceutical sciences part of the aaps advances in the pharmaceutical sciences series book series aaps volume 31 abstract additive manufacturing specifically threedimensional printing 3dp has been in use in the manufacture of medical devices for some time with the fda recently issuing draft guidance for technical considerations in this regard
3d printing of pharmaceuticals springerlink abstract in the new era of medicine 3d printing technique in pharmaceutical manufacturing has already yielded success for example aprecia an fdaapproved pharmaceutical company has launched its first approved product which is not only unique because of a novel manufacturing process but also better than conventional compressed tablets 3d printing is an inexpensive additive
Pdf 3d printing in pharmaceutical and medical 3d printing in pharmaceutical and medical applications ized medicine expressed eg by t he production of small series of interest in the 3d p methods in phar maceutica l sciences
Medical applications of 3d printing springerlink the 3d printing arena is ultimately exciting and endless in opportunities with the fda encouraging the development of science and risk based approaches this chapter will discuss the existing and future medical applications of 3dp and its potential to revolutionise medical practice
Pdf 3d printing amp pharmaceutical manufacturing as 3d printing capabilities develop further safety and regulatory concerns are addressed and the cost of the technology falls contract manufacturers and pharmaceutical companies that experiment
How 3d printing is transforming the pharmaceutical world ondemand pharmaceutical manufacturing advances in 3d printing technology could allow for the ondemand manufacturing of pharmaceuticals allowing for a pharmacy to quickly produce a medication based on demand it is even possible that a patient could utilize a 3d printer at home to print their drugs as they need them